B细胞非霍奇金淋巴瘤
Elisabeth Silkenstedt1, Gilles Salles2, Elias Campo3
1Department of Medicine III, LMU Hospital, Munich, Germany.
Lancet (London, England)
|April 13, 2024
概括
了解B细胞淋巴瘤的进展,包括新的诊断方法和免疫疗法,改善了患者的治疗. 本综述涵盖了这些不同癌症的生物学,分类和管理.
科学领域:
- 血液学
- 癌症学
- 免疫学
背景情况:
- B细胞淋巴瘤是各种各样的恶性瘤,影响任何器官,临床表现和病程各不相同.
- 在高收入国家, 患病率为每10万人中20人.
- 自2017年以来,生物学,诊断和治疗方面的最新进展改善了患者的治疗结果.
研究的目的:
- 提供B细胞非霍奇金淋巴瘤的病理生物学,分类和预后.
- 总结目前对常见亚型的知识和护理标准.
- 突出分子背景和免疫向治疗的新发现.
主要方法:
- 文献审查和近期研究的综合.
- 对病理生物学,分类和预后数据的分析.
- 目前治疗方法的总结,包括向和免疫疗法.
主要成果:
- 更好地了解推动B细胞淋巴瘤发展的分子机制.
- 实施新的诊断方法和向治疗方法.
- 免疫治疗策略的进步,特别是针对免疫系统.
结论:
- 由于更深入的生物学见解和新的治疗方式,在治疗B细胞淋巴瘤方面取得了显著进展.
- 目前的护理标准包括先进的诊断和向/免疫疗法.
- 未来的研究方向集中在进一步破译分子背景和完善基于免疫的治疗方法上.
相关概念视频
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Cells of the Adaptive Immune Response
983
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
983


